Mylan Announces the U.S. District Court Enjoins the FDA from Approving Additional Amlodipine Besylate ANDAs.

0 Comments | M2 Presswire, March, 2007

M2 PRESSWIRE-27 March 2007-Afternoon Movers: Mylan Announces the U.S. District Court Enjoins the FDA from Approving Additional Amlodipine Besylate ANDAs(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:27032007 Market Gainer is quickly emerging as the one stop shop for international small-cap investors looking to stay a step ahead of the markets.

Today's activity on the market has brought this company to the attention of our research team. Mylan Laboratories Inc. (NYSE: MYL), is responding to the attention of investors. Our goal is to create a community of international investors who consistently and effectively capitalize on the enormous gains the small-cap Canadian and American exchanges offer. Mylan Laboratories Inc. (NYSE: MYL) was notified yesterday that the...